Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.88
+0.36 (2.66%)
At close: Aug 29, 2025
2.66%
Market Cap8.64B
Revenue (ttm)829.27M
Net Income (ttm)35.10M
Shares Out622.33M
EPS (ttm)0.06
PE Ratio224.80
Forward PE48.81
Dividendn/a
Ex-Dividend Daten/a
Volume17,392,000
Average Volume19,521,345
Open13.58
Previous Close13.52
Day's Range13.33 - 14.20
52-Week Range7.51 - 25.00
Beta-0.18
RSI38.75
Earnings DateAug 27, 2025

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 760
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.